Filament Health Corp Stock Performance
| FLHLF Stock | USD 0.03 0.01 14.29% |
Filament Health holds a performance score of 5 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 0.15, which means not very significant fluctuations relative to the market. As returns on the market increase, Filament Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding Filament Health is expected to be smaller as well. Use Filament Health total risk alpha, expected short fall, period momentum indicator, as well as the relationship between the value at risk and rate of daily change , to analyze future returns on Filament Health.
Risk-Adjusted Performance
5 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Filament Health Corp are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile essential indicators, Filament Health reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 878.4 K | |
| Total Cashflows From Investing Activities | -265.8 K |
Filament |
Filament Health Relative Risk vs. Return Landscape
If you would invest 3.33 in Filament Health Corp on August 26, 2024 and sell it today you would lose (0.33) from holding Filament Health Corp or give up 9.91% of portfolio value over 90 days. Filament Health Corp is currently producing 1.0761% returns and takes up 15.8593% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Filament, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Filament Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Filament Health's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Filament Health Corp, and traders can use it to determine the average amount a Filament Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0679
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | FLHLF | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 15.86 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.08 actual daily | 21 79% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Filament Health is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Filament Health by adding it to a well-diversified portfolio.
Filament Health Fundamentals Growth
Filament OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Filament Health, and Filament Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Filament OTC Stock performance.
| Return On Equity | -0.4 | |||
| Return On Asset | -0.21 | |||
| Operating Margin | (31.94) % | |||
| Current Valuation | 7.57 M | |||
| Shares Outstanding | 174.95 M | |||
| Price To Book | 0.85 X | |||
| Price To Sales | 103.44 X | |||
| EBITDA | (9.08 M) | |||
| Cash And Equivalents | 3 M | |||
| Cash Per Share | 0.02 X | |||
| Total Debt | 868.91 K | |||
| Debt To Equity | 0.06 % | |||
| Book Value Per Share | 0.08 X | |||
| Cash Flow From Operations | (5.41 M) | |||
| Earnings Per Share | (0.04) X | |||
| Total Asset | 17.84 M | |||
About Filament Health Performance
By analyzing Filament Health's fundamental ratios, stakeholders can gain valuable insights into Filament Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Filament Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Filament Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Filament Health Corp. operates as a natural psychedelic drug discovery and extraction technology company. It propagates psychedelic plants conducts genetic research performs extraction procedures runs in-house trials and distributes IP and drug candidates to drug developers, researchers, and other licensed parties. Filament Health is traded on OTC Exchange in the United States.Things to note about Filament Health Corp performance evaluation
Checking the ongoing alerts about Filament Health for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Filament Health Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Filament Health Corp is way too risky over 90 days horizon | |
| Filament Health Corp has some characteristics of a very speculative penny stock | |
| Filament Health Corp appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (9.25 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Filament Health Corp has accumulated about 3 M in cash with (5.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02. | |
| Roughly 66.0% of the company shares are held by company insiders |
- Analyzing Filament Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Filament Health's stock is overvalued or undervalued compared to its peers.
- Examining Filament Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Filament Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Filament Health's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Filament Health's otc stock. These opinions can provide insight into Filament Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Filament OTC Stock analysis
When running Filament Health's price analysis, check to measure Filament Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Filament Health is operating at the current time. Most of Filament Health's value examination focuses on studying past and present price action to predict the probability of Filament Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Filament Health's price. Additionally, you may evaluate how the addition of Filament Health to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |